These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24589724)

  • 81. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients.
    Kamijo-Ikemori A; Sugaya T; Yasuda T; Kawata T; Ota A; Tatsunami S; Kaise R; Ishimitsu T; Tanaka Y; Kimura K
    Diabetes Care; 2011 Mar; 34(3):691-6. PubMed ID: 21273494
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
    Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
    Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy.
    Packham DK; Ivory SE; Reutens AT; Wolfe R; Rohde R; Lambers Heerspink H; Dwyer JP; Atkins RC; Lewis J;
    Nephron Clin Pract; 2011; 118(4):c331-8. PubMed ID: 21293156
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy.
    Ding X; Wang X; Du J; Han Q; Zhang D; Zhu H
    Front Endocrinol (Lausanne); 2022; 13():866252. PubMed ID: 36034457
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
    Hinokio Y; Suzuki S; Hirai M; Suzuki C; Suzuki M; Toyota T
    Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
    Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
    Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical Implication of Cystatin C and β2-Microglobulin in Early Detection of Diabetic Nephropathy.
    Chen H; Li H
    Clin Lab; 2017 Feb; 63(2):241-247. PubMed ID: 28182344
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [TBL] [Abstract][Full Text] [Related]  

  • 92. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
    El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Study of diabetic nephropathy in the proteomic era.
    Thongboonkerd V
    Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.
    Van JA; Scholey JW; Konvalinka A
    J Am Soc Nephrol; 2017 Apr; 28(4):1050-1061. PubMed ID: 28159781
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Urinary neutrophil gelatinase-associated lipocalin in type 2 diabetes: Relation to nephropathy and retinopathy.
    Hosny SS; Bekhet MM; Hebah HA; Mohamed NR
    Diabetes Metab Syndr; 2018 Nov; 12(6):1019-1024. PubMed ID: 29960862
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
    Darmayanti S; Lesmana R; Meiliana A; Abdulah R
    Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
    Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
    J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes.
    Kobayashi H; Looker HC; Satake E; Saulnier PJ; Md Dom ZI; O'Neil K; Ihara K; Krolewski B; Galecki AT; Niewczas MA; Wilson JM; Doria A; Duffin KL; Nelson RG; Krolewski AS
    Kidney Int; 2022 Aug; 102(2):370-381. PubMed ID: 35618095
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Target amplification-free detection of urinary microRNA for diabetic nephropathy diagnosis with electrocatalytic reaction.
    Ngamdee T; Chalermwatanachai T; Siriwan C; Warachit O; Rijiravanich P; Surareungchai W
    Anal Bioanal Chem; 2022 Jul; 414(18):5695-5707. PubMed ID: 35476120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.